US biotech firms address analysts at ag forum

By staff reporter

- Last updated on GMT

Related tags: Fruit, Monsanto

The nation's leading biotech firms yesterday outlined their
performance and expectations at the eleventh annual Agricultural
Biotech Forum held by investment banking firm Goldman Sachs.

Amongst speakers addressing investment analysts were executives from DuPont, Monsanto, Bunge, Dow Chemical Company and Corn Products International. According to DuPont Agriculture and Nutrition vice president Erik Fyrwald, the group expects to grow sales and earnings in 2007 as it also increases investments in high growth opportunities in plant genetics and biotechnology. "We have a much stronger seed product offering this year and are rampingup biotech traits for full supply in 2008 and beyond. We expect solid growth in 2007, moderated by increased investments this year that will drive further growth over the next five years,"​ said Fyrwald. Fyrwald said the company has significantly increased the amount of seed with the three-way stack of biotech traits that are in high demand. At the same time, DuPont has increased its investment in the technology pipeline for its next-generation biotech traits and advanced crop protection products. In the past year, 44 percent of the DuPont crop genetics research pipeline advanced to a phase closer to the market, including four projects that moved to the pre-launch phase. In the past two years, 90 percent of the DuPont crop genetics pipeline has advanced phases in the company's research pipeline, it said. In Monsanto's address, the firm's chairman, president and chief executive officer Hugh Grant outlined pre-season highlights for its US seeds and traits business. "The 2007 season is shaping up to be an important year for agriculture. While we'd expect numerous ag companies to benefit from the expected rising tide in corn acres, Monsanto's unique ability to deliver a total performance package - across our seed and trait portfolio - will continue to serve as a key growth differentiator for our business within this expanding market and into the next decade,"​ said Grant. He also discussed how Monsanto's seeds and traits business is expected to be shaped by six key factors leading up to the next decade. These include: its US and ex-US corn seeds and traits business; its international traits business; its cotton business; its Seminis fruit and vegetable seed business; and its R&D pipeline. "While it's still early in our fiscal year, we're on track and making real progress against each of these six factors. Our US business remains focused on growing corn seed sales, increasing the penetration of our trait technologies, and accelerating the adoption of our stacked-trait products,"​ said Grant.

Related news

Show more

Related products

show more

Pectin's

Pectin's "a-peeling" future

Cargill | 08-Aug-2022 | Technical / White Paper

Familiar, plant-based, highly functional… today's pectin ticks off a lot of boxes for consumers and product developers alike. Learn how this humble...

Sustainable sweetness

Sustainable sweetness

Cargill | 04-Aug-2022 | Insight Guide

According to proprietary Cargill research, more than half of consumers indicate they are more likely to purchase a product if it includes a sustainability...

Adding value as your partner in oils.

Adding value as your partner in oils.

ADM | 27-Jul-2022 | Infographic

Download our new oils infographic and learn how ADM’s value added services can help you overcome many of the daily challenges you face. From reducing risks...

Adding value as your partner in oils.

Adding value as your partner in oils.

ADM advances regenerative agriculture | 24-Jun-2022 | Infographic

ADM’s extensive oil portfolio can help you create the perfect taste and texture across a variety of applications. Download our infographic to learn how...

Related suppliers

Follow us

Products

View more

Webinars